Northern Trust’s United Therapeutics UTHR Stock Holding History

Northern Trust’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$259M	Buy	436,566 +18,139	+4%	+$9.03M	0.03%	411
2025 Q4	$204M	Sell	418,427 -28,591	-6%	-$13.3M	0.03%	481
2025 Q3	$187M	Sell	447,018 -5,201	-1%	-$1.75M	0.02%	515
2025 Q2	$130M	Sell	452,219 -19,146	-4%	-$5.72M	0.02%	610
2025 Q1	$145M	Sell	471,365 -17,489	-4%	-$5.99M	0.02%	565
2024 Q4	$172M	Buy	488,854 +110,298	+29%	+$40.5M	0.02%	517
2024 Q3	$136M	Buy	378,556 +15,826	+4%	+$5.35M	0.02%	540
2024 Q2	$116M	Buy	362,730 +48,619	+15%	+$12.9M	0.02%	576
2024 Q1	$72.2M	Sell	314,111 -59,683	-16%	-$13.5M	0.01%	774
2023 Q4	$82.2M	Sell	373,794 -17,670	-5%	-$4.07M	0.01%	700
2023 Q3	$88.4M	Sell	391,464 -5,054	-1%	-$1.16M	0.02%	640
2023 Q2	$87.5M	Buy	396,518 +204	+0.1%	+$45.2K	0.02%	646
2023 Q1	$88.8M	Buy	396,314 +58,133	+17%	+$14.3M	0.02%	644
2022 Q4	$94M	Buy	338,181 +2,584	+0.8%	+$652K	0.02%	603
2022 Q3	$70.3M	Sell	335,597 -947	-0.3%	-$212K	0.02%	679
2022 Q2	$79.3M	Sell	336,544 -5,751	-2%	-$1.17M	0.02%	645
2022 Q1	$61.4M	Sell	342,295 -11,430	-3%	-$2.18M	0.01%	890
2021 Q4	$76.4M	Sell	353,725 -5,335	-1%	-$1.05M	0.01%	802
2021 Q3	$66.3M	Sell	359,060 -7,845	-2%	-$1.55M	0.01%	881
2021 Q2	$65.8M	Sell	366,905 -11,211	-3%	-$2.14M	0.01%	920
2021 Q1	$63.2M	Buy	378,116 +27,724	+8%	+$4.62M	0.01%	937
2020 Q4	$53.2M	Sell	350,392 -2,496	-0.7%	-$328K	0.01%	1028
2020 Q3	$35.6M	Sell	352,888 -11,431	-3%	-$1.25M	0.01%	1154
2020 Q2	$44.1M	Buy	364,319 +480	+0.1%	+$54K	0.01%	981
2020 Q1	$34.5M	Buy	363,839 +9,389	+3%	+$892K	0.01%	1016
2019 Q4	$31.2M	Buy	354,450 +10,867	+3%	+$956K	0.01%	1377
2019 Q3	$27.4M	Sell	343,583 -112,550	-25%	-$9.06M	0.01%	1425
2019 Q2	$35.6M	Sell	456,133 -9,524	-2%	-$891K	0.01%	1255
2019 Q1	$54.7M	Buy	465,657 +36,385	+8%	+$4.24M	0.01%	894
2018 Q4	$46.7M	Buy	429,272 +19,221	+5%	+$2.23M	0.01%	913
2018 Q3	$52.4M	Sell	410,051 -33,112	-7%	-$4.1M	0.01%	990
2018 Q2	$50.1M	Buy	443,163 +11,655	+3%	+$1.28M	0.01%	1007
2018 Q1	$48.5M	Buy	431,508 +21,472	+5%	+$2.73M	0.01%	1021
2017 Q4	$60.7M	Sell	410,036 -10,299	-2%	-$1.31M	0.02%	834
2017 Q3	$49.3M	Sell	420,335 -5,761	-1%	-$736K	0.01%	960
2017 Q2	$55.3M	Sell	426,096 -26,592	-6%	-$3.32M	0.02%	851
2017 Q1	$61.3M	Buy	452,688 +23,339	+5%	+$3.54M	0.02%	783
2016 Q4	$61.6M	Sell	429,349 -49,486	-10%	-$6.32M	0.02%	736
2016 Q3	$56.5M	Sell	478,835 -18,315	-4%	-$2.2M	0.02%	775
2016 Q2	$52.7M	Sell	497,150 -5,570	-1%	-$621K	0.02%	783
2016 Q1	$57.8M	Buy	502,720 +16,751	+3%	+$2.12M	0.02%	723
2015 Q4	$76.1M	Buy	485,969 +375	+0.1%	+$54.6K	0.03%	576
2015 Q3	$63.7M	Sell	485,594 -10,637	-2%	-$1.71M	0.02%	651
2015 Q2	$86.3M	Buy	496,231 +60,646	+14%	+$10.9M	0.03%	561
2015 Q1	$75.1M	Sell	435,585 -7,244	-2%	-$1.1M	0.02%	633
2014 Q4	$57.3M	Sell	442,829 -93,521	-17%	-$12.1M	0.02%	736
2014 Q3	$69M	Buy	536,350 +87,029	+19%	+$8.97M	0.02%	613
2014 Q2	$39.8M	Sell	449,321 -55,801	-11%	-$5.37M	0.01%	965
2014 Q1	$47.5M	Buy	505,122 +16,115	+3%	+$1.65M	0.01%	864
2013 Q4	$55.3M	Buy	489,007 +50,008	+11%	+$4.51M	0.02%	715
2013 Q3	$34.6M	Sell	438,999 -7,597	-2%	-$555K	0.01%	970
2013 Q2	$29.4M	Buy	+446,596	New	+$28.8M	0.01%	1049

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Northern Trust's UTHR Position: Q1 2026 in Review

Northern Trust increased its United Therapeutics (UTHR) stake by 4.3% in Q1 2026, buying an estimated $9.03M and bringing the position to 436,566 shares worth $259M. The position accounts for 0.03% of the portfolio, ranked #411.

Northern Trust first reported a position in UTHR in Q2 2013 and has held it in 52 quarters since. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

Northern Trust held 436,566 shares of United Therapeutics worth $259M as of Q1 2026.
Northern Trust bought 18,139 United Therapeutics shares in Q1 2026, an estimated $9.03M.
United Therapeutics made up 0.03% of Northern Trust's portfolio in Q1 2026, its #411 holding.
Northern Trust first reported a position in United Therapeutics in Q2 2013 and has held it in 52 quarters since.
850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.